HMGN3 / TRIP7 antibody
Principal name
HMGN3 / TRIP7 antibody
Alternative names for HMGN3 / TRIP7 antibody
TR-interacting protein 7, PNAS-24, High mobility group nucleosome-binding domain-containing protein 3, Thyroid receptor-interacting protein 7
Ncbi ID
NP_004233, 9606, NM_001201362, NP_001188291, NP_620058, NM_138730, NM_004242, NP_001188291.1, NP_080398.1, BC005693, NM_175074, NM_026122, NM_001007020
Available reactivities
Available hosts
Available applications
Enzyme Immunoassay (E), Western blot / Immunoblot (WB)
Background of HMGN3 / TRIP7 antibody
- Kit Component:
- - KN307828G1, Hmgn3 gRNA vector 1 in pCas-Guide vector
- KN307828G2, Hmgn3 gRNA vector 2 in pCas-Guide vector
- KN307828D, donor vector containing left and right homologous arms and Luciferase-Puro functional cassette
- GE100003, scramble sequence in pCas-Guide vector - CRISPR Manual:
- CRISPR/CAS9 Genome Editing Manual
General readings
Ueda, T., et al. Mol. Cell. Biol. 29(19):5264-5276(2009)
Wu, C., et al. Proteomics 7(11):1775-1785(2007)
Olsen, J.V., et al. Cell 127(3):635-648(2006)
Olsen, J.V., et al. Cell 127(3):635-648(2006)
Leong, P.W., et al. Virology 295(1):147-159(2002)
Human 721_B; WB Suggested Anti-HMGN3 Antibody. . Titration: 1.0 ug/ml. . Positive Control: 721_B Whole Cell. HMGN3 is supported by BioGPS gene expression data to be expressed in 721_B.; HMGN3 antibody - middle region (ARP61955_P050) in Human 721_B cells using Western Blot
Western blot analysis of HMGN3 (arrow) using HMGN3 / TRIP7 Antibody (N-term) Cat.-No AP52062PU-N. 293 cell lysates (2 ug/lane) either nontransfected (Lane 1) or transiently transfected (Lane 2) with the HMGN3 gene.
Western blot analysis of HMGN3 / TRIP7 Antibody (N-term) Cat.-No AP52062PU-N in MDA-MB453 cell line lysates (35ug/lane). This demonstrates the HMGN3 antibody detected the HMGN3 protein (arrow).
Host: Rabbit; Target Name: HMGN3; Sample Tissue: Pancreas Tumor lysates; Antibody Dilution: 1.0 ug/ml
Host: Rabbit; Target Name: Hmgn3; Sample Tissue: Mouse Small Intestine lysates; Antibody Dilution: 1.0 ug/ml
Primary Antibodies
| Catalog No. | Host | Iso. | Clone | Pres. | React. | Applications | |
|---|---|---|---|---|---|---|---|
| TA339226 | HMGN3 / TRIP7 antibody |
||||||
| Rabbit Polyclonal Anti-HMGN3 | |||||||
 |
Rabbit | IgG | Purified | Bov, Can, Eq, GP, Hu, Ms, Por, Rb, Rt, Ze | WB |
50 µg /
€360.00
|
|
| OriGene Technologies, Inc. | |||||||
| TA343180 | HMGN3 / TRIP7 antibody |
||||||
| Rabbit Polyclonal Anti-HMGN3 Antibody | |||||||
 |
Rabbit | IgG | Purified | Bov, Can, Eq, GP, Hu, Ms, Por, Rb, Rt | WB |
50 µg /
€360.00
|
|
| OriGene Technologies, Inc. | |||||||
| AP52062PU-N | HMGN3 / TRIP7 (N-term) antibody |
||||||
 |
Rabbit | Ig | Aff - Purified | Hu | WB |
0.4 ml /
€370.00
|
|
| Acris Antibodies GmbH | |||||||
 +1 additional image |
|||||||
Proteins & Growth Factors
| Catalog No. | Species | Pres. | Purity | Source | |
|---|---|---|---|---|---|
| TP302339 | HMGN3 / TRIP7 (transcript variant 2) |
||||
| Recombinant protein of human high mobility group nucleosomal binding domain 3 (HMGN3), transcript variant 2 | |||||
 |
Human | > 80 % Preparation: Recombint protein was captured through anti-DDK affinity column followed by conventiol chromatography steps. Purity Detail: > 80% as determined by SDS-PAGE and Coomassie blue staining. |
HEK293 cells |
20 µg /
€438.00
|
|
| OriGene Technologies, Inc. | |||||
|
|||||
| TP313403 | HMGN3 / TRIP7 (transcript variant 1) |
||||
| Recombinant protein of human high mobility group nucleosomal binding domain 3 (HMGN3), transcript variant 1 | |||||
 |
Human | > 80 % Preparation: Recombint protein was captured through anti-DDK affinity column followed by conventiol chromatography steps. Purity Detail: > 80% as determined by SDS-PAGE and Coomassie blue staining. |
HEK293 cells |
20 µg /
€680.00
|
|
| OriGene Technologies, Inc. | |||||
| AR51616PU-N | HMGN3 / TRIP7 (1-77, His-tag) |
||||
 |
Human | Purified | > 95 % by SDS - PAGE | E. coli |
0.5 mg /
€730.00
|
| Acris Antibodies GmbH | |||||
| AR51616PU-S | HMGN3 / TRIP7 (1-77, His-tag) |
||||
|
Human | Purified | > 95 % by SDS - PAGE | E. coli |
0.1 mg /
€300.00
|
| Acris Antibodies GmbH | |||||
Lysates
| Catalog No. | ||
|---|---|---|
| LY408537 | HMGN3 overexpression lysate |
|
 |
0.1 mg /
€295.00
|
|
| OriGene Technologies, Inc. | ||
| LY418127 | HMGN3 overexpression lysate |
|
|
0.1 mg /
€295.00
|
|
| OriGene Technologies, Inc. |
Human Lenti ORF Particles
| Catalog No. | ||
|---|---|---|
| RC213403L2V | Lenti ORF particles, HMGN3 (mGFP-tagged) - Human high mobility group nucleosomal binding domain 3 (HMGN3), transcript variant 1, 200 uL, >10^7 TU/mL |
|
|
200 µl /
€907.00
|
|
| OriGene Technologies, Inc. | ||
| RC202339L2V | Lenti ORF particles, HMGN3 (mGFP-tagged) - Human high mobility group nucleosomal binding domain 3 (HMGN3), transcript variant 2, 200 uL, >10^7 TU/mL |
|
|
200 µl /
€907.00
|
|
| OriGene Technologies, Inc. | ||
| RC213403L1V | Lenti ORF particles, HMGN3 (Myc-DDK tagged) - Human high mobility group nucleosomal binding domain 3 (HMGN3), transcript variant 1 , 200 uL, >10^7 TU/mL |
|
|
200 µl /
€804.00
|
|
| OriGene Technologies, Inc. | ||
| RC202339L1V | Lenti ORF particles, HMGN3 (Myc-DDK tagged) - Human high mobility group nucleosomal binding domain 3 (HMGN3), transcript variant 2 , 200 uL, >10^7 TU/mL |
|
|
200 µl /
€804.00
|
|
| OriGene Technologies, Inc. | ||
Mouse Lenti ORF Particles
Rat Lenti ORF Particles
| Catalog No. | ||
|---|---|---|
| RR212413L2V | Lenti ORF particles, Hmgn3 (GFP-tagged ORF) - Rat high mobility group nucleosomal binding domain 3 (Hmgn3), 200 uL, >10^7 TU/mL |
|
|
200 µl /
€907.00
|
|
| OriGene Technologies, Inc. | ||
